NASDAQ: FTH

Faeth Therapeutics, Inc.

$23.12
▼ -1.88 (-7.52%)as of 2026-07-01
1-year price · 252 sessions
Key stats
52-week range$23.12
$6.80$35.07
Today
Open
24.18
Day high
24.38
Day low
22.50
Prev close
25.00
Volume
110K
Valuation
Mkt cap
$31M
P/E (TTM)
—
EPS (TTM)
—
P/B
—
P/S
—
Dividend
Yield
—
Per share
—
Insider & institutional activity · SEC Form 4 / 13F
  • ▲Insiders net buying $860K over the last 3 months (16 open-market buys, 0 sales)
  • ◆Cluster buying — multiple insiders bought within days
See all FTH insider trades →

Faeth Therapeutics, Inc. (FTH) is a Healthcare company listed on NASDAQ. The stock is up 182% over the past year. Over the trailing 3 months, insiders filed 16 open-market buys and 0 sales (SEC Form 4).

Faeth Therapeutics, Inc. (FTH) financials & analyst ratings

Fundamentals (TTM)

Margins
Gross margin2740.8%
Operating margin3826.9%
Net margin3802.5%
FCF margin497.1%
Growth & returns
Revenue growth—
Revenue growth (fwd)—
EPS growth—
Return on equity-96.5%
Return on assets-89.8%

Analyst consensus · 2 analysts

BuyBuy 2Hold 0Sell 0Avg target $59 (+153.0%)Range $57–$60

Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.

Track FTH with Drillr

SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.

Try Drillr for free